Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
137.00
Ask:
140.00
Spread: 3.00 (2.19%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement-COVID-19 & Preliminary Statement

23 Mar 2020 17:47

RNS Number : 2844H
Xaar PLC
23 March 2020
 

Xaar plc

 

Trading update and revised date for full year results 

 

Xaar plc ("Xaar" or the "Group"), the leading inkjet printing technology Group, announces a confirmation of previous guidance and a revised date for the presentation of full year results.

 

Full year results

 

Preliminary financial statements for the 12 months ended 31 December 2019 were scheduled to be released 24 March 2020.

 

The FCA has strongly requested all listed companies observe a moratorium on the publication of preliminary financial statements for at least two weeks.

 

In compliance with this request, Xaar will not be releasing preliminary financial statements, but will publish full audited financial statements within four months of the financial year end, subject to any further guidance from the FCA.

 

Trading update

 

Xaar continues to make good progress with its strategy and re-iterates the preliminary guidance for 2019:

 

The Group expects to report revenues for its continuing operations of £49.4 million for the year ended 31 December 2019.

 

Group cash balances (including cash held for investment in Xaar 3D) were £25.3 million at 31 December 2019.

 

COVID19 - Update

 

The health, safety and security of our employees is our upmost priority and appropriate actions have been taken to our operational procedures to mitigate risk.

 

The Group's trading performance in 2020 to date has been in line with expectations. No orders have been cancelled, however we are mindful of the rapidly changing environment in which the business is operating.

 

While the full implications of COVID-19 on the financial performance for the current financial year are difficult to determine at this stage, the Board remains confident in the long-term prospects of the Group.

 

 

Enquiries:

Xaar plc

+44 (0)1223 423 663 

John Mills, Chief Executive Officer

Ian Tichias, Chief Finance Officer

 

 

Tulchan Communications

+44 (0)20 7353 4200

James Macey White

Giles Kernick

Hollie Ralston

 

About XaarXaar is a world leader in the development of digital inkjet technology. Our technology drives the conversion of analogue printing and manufacturing methods to digital inkjet which is more efficient, more economical and more productive than the traditional methods which have been in use for years. We design and manufacture printheads as well as systems for product decoration and industrial 3D Printing which use our inkjet technology. We are the only truly independent inkjet technology company with over 25 years of know how. We offer unrivalled inkjet expertise including technology and printhead design and development and manufacture highly customised product decoration systems and industrial 3D Printing for volume manufacturing. Our unique technologies and products are the leading enabler for innovation and for driving supply chain efficiencies for many industries. Information about Xaar is at www.xaar.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUQCWUPUGMW
Date   Source Headline
26th Apr 20063:56 pmRNSDirector/PDMR Shareholding
24th Apr 20064:29 pmRNSResult of AGM
24th Apr 20067:01 amRNSAGM positive trading update
18th Apr 20066:05 pmRNSDirector/PDMR Shareholding
18th Apr 200611:31 amRNSAnnual Information Update
5th Apr 20064:59 pmRNSDirector/PDMR Shareholding
30th Mar 20065:24 pmRNSHolding(s) in Company
14th Mar 20066:21 pmRNSDirector/PDMR Shareholding
14th Mar 20067:01 amRNSFinal Results
21st Feb 20067:01 amRNSNotice of Preliminary Results
14th Feb 20065:29 pmRNSHolding(s) in Company
12th Jan 20067:00 amRNSPeriod-end trading update
29th Nov 20057:00 amRNSHolding(s) in Company
25th Nov 20051:02 pmRNSDirector/PDMR Shareholding
23rd Nov 20055:43 pmRNSDirector/PDMR Shareholding
22nd Nov 20056:30 pmRNSDirector/PDMR Shareholding
7th Nov 20057:00 amRNSAnalyst and investor seminar
3rd Nov 20056:17 pmRNSHolding(s) in Company
24th Oct 20054:13 pmRNSDirector/PDMR Shareholding
24th Oct 20054:11 pmRNSDirector/PDMR Shareholding
24th Oct 20052:47 pmRNSHolding(s) in Company
14th Oct 20056:13 pmRNSHolding(s) in Company
14th Oct 20056:05 pmRNSHolding(s) in Company
12th Oct 200512:44 pmRNSDirector/PDMR Shareholding
10th Oct 20055:22 pmRNSDirector/PDMR Shareholding
6th Oct 20057:00 amRNSHolding(s) in Company
5th Oct 200510:59 amRNSDirector/PDMR Shareholding
27th Sep 20056:11 pmRNSDirector/PDMR Shareholding
20th Sep 20051:06 pmRNSDirector/PDMR Shareholding
14th Sep 20057:02 amRNSAppointment of director
14th Sep 20057:01 amRNSInterim Results
12th Sep 20057:00 amRNSInvestment in trade partner
16th Aug 20055:51 pmRNSNotice of Interim Results
16th Aug 20052:30 pmRNSNotice of Interim Results
28th Jul 20054:32 pmRNSHolding(s) in Company
21st Jul 200510:28 amRNSHolding(s) in Company
6th Jul 20057:00 amRNSPositive half year update
4th Jul 200511:36 amRNSHolding(s) in Company
4th Jul 200511:26 amRNSDirector/PDMR Shareholding
8th Jun 20056:31 pmRNSHolding(s) in Company
2nd Jun 20054:05 pmRNSHolding(s) in Company
26th May 20054:22 pmRNSHolding(s) in Company
26th May 20052:15 pmRNSDirector Shareholding
20th May 20059:28 amRNSHolding(s) in Company
13th May 20057:01 amRNSSystems integration partner
5th May 20056:27 pmRNSHolding(s) in Company
29th Apr 200511:45 amRNSHolding(s) in Company
28th Apr 20052:30 pmRNSResult of AGM
28th Apr 20057:00 amRNSPositive AGM update
25th Apr 20055:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.